BIOHAVEN LTD (BHVN) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:BHVN - VGG1110E1079 - Common Stock
10.125 USD
+0.57 (+6.02%)
ChartMill assigns a Buy % Consensus number of 82% to BHVN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.95. This target is 97.07% above the current price.
BHVN was analyzed by 24 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about BHVN.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
BHVN was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-11-26 | UBS | Downgrade | Buy -> Neutral |
| 2025-11-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-18 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-06 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-11-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-05 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-09-17 | Citigroup | Initiate | Buy |
| 2025-09-16 | UBS | Maintains | Buy -> Buy |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-08-19 | BTIG | Maintains | Buy -> Buy |
| 2025-08-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-08-12 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-12 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-19 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-05-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | Deutsche Bank | Initiate | Buy |
| 2024-12-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
BIOHAVEN LTD / BHVN FAQ
Can you provide the average price target for BIOHAVEN LTD stock?
24 analysts have analysed BHVN and the average price target is 19.95 USD. This implies a price increase of 97.07% is expected in the next year compared to the current price of 10.125.
What is the consensus rating for BHVN stock?
The consensus rating for BIOHAVEN LTD (BHVN) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BHVN stock?
The number of analysts covering BIOHAVEN LTD (BHVN) is 24.